过去一年中进入临床试用和即将进入临床试用的抗癌新药的数量明显增加。本文报道27种,其中有16种新药属初次报道。这些新药包括3种铂类似物,两种新的蒽环类和一些新结构的化合物。其中研究结果较肯定的是干扰素,对多种临床肿瘤均显示疗效。左旋2-氨3-氯4、5-二氢5-异(口恶)唑醋酸(Ac(?)vicin) The number of new anti-cancer drugs that entered clinical trials and are about to enter clinical trials has increased significantly in the past year. This article reports 27 species, 16 of which are reported for the first time. These new drugs include three platinum analogues, two new anthracyclines and some new structural compounds. Among the findings, interferon is more positive, showing efficacy in a variety of clinical tumors. Levorotatory 2-Amino 3-chloro 4,5-dihydro-5-isoquinoline Acetic acid (Ac(?)vicin)